Hearing Technologies

Featured image for “Amplifon Secures €75M Sustainability-Linked Credit Facility with Mediobanca”
Dec. 19, 2024

Amplifon Secures €75M Sustainability-Linked Credit Facility with Mediobanca

HHTM
MILAN, ITALY – Amplifon, a global leader in hearing solutions and services, announced the signing of a new sustainability-linked credit facility with Mediobanca – Banca di Credito Finanziario S.p.A., for a total amount of €75 million (~$80.2M USD). This loan, amortizing with a 5-year term, builds on Amplifon’s existing five sustainability-linked credit facilities, reflecting the company’s commitment to further integrating
Featured image for “Knowles Corporation to Showcase Advanced Audio Technologies at CES 2025”
Dec. 17, 2024

Knowles Corporation to Showcase Advanced Audio Technologies at CES 2025

HHTM
ITASCA, ILLINOIS — Knowles Corporation (NYSE: KN), a provider of high-performance capacitors, radio frequency (RF) filtering products, advanced micro-acoustic microphones, and balanced armature speakers, will unveil its latest audio technologies at CES 2025.The company will demonstrate innovations designed for hearing health, true wireless stereo (TWS), open wearable stereo (OWS), and audiophile applications. CES attendees can visit Knowles at the Venetian
Featured image for “Grason-Stadler Introduces GSI AMTAS Updates”
Dec. 03, 2024

Grason-Stadler Introduces GSI AMTAS Updates

HHTM
EDEN PRAIRIE, MINNESOTA – Grason-Stadler (GSI), the leader in clinical audiometric systems, is proud to announce the release of the latest update to its Automated Method for Testing Auditory Sensitivity (AMTAS) product. This new version brings enhanced functionality and improved ease of use, further solidifying Grason-Stadler’s commitment to delivering cutting-edge solutions for audiometric testing. Key Features of GSI AMTAS V2.0
Featured image for “All Mobile Phones to Be Hearing Aid Compatible Under New FCC Mandate”
Nov. 27, 2024

All Mobile Phones to Be Hearing Aid Compatible Under New FCC Mandate

HHTM
Smartphones have become integral to daily life, enabling tasks like online learning, streaming entertainment, managing finances, and tracking health. As of early 2024, an estimated 97% of Americans own a smartphone, underscoring their essential role in modern living. This prevalence has also shaped advancements in hearing aids, which now integrate seamlessly with smartphones to enhance user experiences. In recent years,
Featured image for “Signia Active Pro IX Hearing Aids Now Available in the U.S.”
Nov. 22, 2024

Signia Active Pro IX Hearing Aids Now Available in the U.S.

HHTM
ISELIN, NEW JERSEY – Signia has announced that Signia Active Pro IX is now available in the United States. Featuring advanced hearing technology, an industry-leading hearing-in-noise platform, and a familiar earbud design, Signia Active Pro IX aims to address barriers to hearing aid adoption while supporting better hearing for individuals with hearing loss. “Signia Active Pro IX combines the ease
Featured image for “MED-EL Receives FDA Approval of Expanded Candidacy Indications and Hearing Preservation Results for Cochlear Implant System”
Nov. 13, 2024

MED-EL Receives FDA Approval of Expanded Candidacy Indications and Hearing Preservation Results for Cochlear Implant System

HHTM
DURHAM, NORTH CAROLINA – MED-EL Corporation announced that the U.S. Food and Drug Administration (FDA) has approved new indications for its cochlear implant system, including the first-ever approval related to hearing preservation outcomes. The updated indication in the United States now includes adults with bilateral moderate-to-profound sensorineural hearing loss and aided word recognition scores of 50% or less in the
Featured image for “Rexton Expands Reach Platform with Discreet, Rechargeable inoX-CIC Li Hearing Aids”
Nov. 12, 2024

Rexton Expands Reach Platform with Discreet, Rechargeable inoX-CIC Li Hearing Aids

HHTM
ISELIN, NEW JERSEY – Rexton has introduced the Rexton Reach inoX-CIC Li, a rechargeable completely-in-canal (CIC) hearing aid, as an addition to its Rexton Reach platform. This new hearing aid is designed to provide wearers with a discreet, convenient solution equipped with advanced stabilization technology to improve hearing in challenging environments. The Rexton Reach inoX-CIC Li features an instant-fit design
Featured image for “Unitron Expands Vivante Portfolio with Launch of Stride V-M and Stride V-SP”
Nov. 12, 2024

Unitron Expands Vivante Portfolio with Launch of Stride V-M and Stride V-SP

HHTM
AURORA, ILLIONOIS – Unitron has announced the official launch of two new Vivante™ styles, Stride™ V-M and Stride V-SP, expanding the company’s range of hearing solutions on the Vivante platform and providing patients with more options to meet their needs. Designed for flexibility and comfort, Stride V-M and Stride V-SP increase the variety of choices available within Unitron’s portfolio. Both
Featured image for “Starkey’s Edge AI Hearing Aids Now Available Through VA and DoD”
Nov. 11, 2024

Starkey’s Edge AI Hearing Aids Now Available Through VA and DoD

HHTM
EDEN PRAIRIE, MINNESOTA – Starkey, the only American-owned major hearing aid manufacturer, last week announced that its newest hearing technology, Edge AI, is now available through the Veterans Affairs Administration, Department of Defense and the Indian Health Service. Building on the success of Genesis AI, “Edge AI represents the next leap in intelligent hearing technology, redefining the patient and provider
Featured image for “Envoy Medical Receives FDA Approval to Initiate Pivotal Clinical Study for Fully Implanted Acclaim® Cochlear Implant”
Nov. 04, 2024

Envoy Medical Receives FDA Approval to Initiate Pivotal Clinical Study for Fully Implanted Acclaim® Cochlear Implant

HHTM
WHITE BEAR LAKE, MINNESOTA — Envoy Medical®, Inc. (NASDAQ: “COCH”), a hearing health company specializing in fully implanted hearing systems, announced the U.S. Food and Drug Administration’s (FDA) approval of its Investigational Device Exemption (IDE) application for a pivotal study of the Acclaim® Fully Implanted Cochlear Implant. The Acclaim® technology includes an implanted sensor that leverages the ear’s natural anatomy